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♦ Background: Patients are satisfied with their kidney care but 
want more support in making dialysis choices. Predialysis leaflets 
vary across services, with few being sufficient to enable patients’ 
informed decision making. We describe the acceptability of a 
patient decision aid and feasibility of evaluating its effectiveness 
within usual predialysis practice.
♦ Methods: Prospective non-randomized comparison design, 
Usual Care or Usual Care Plus Yorkshire Dialysis Decision Aid 
Booklet (+YoDDA), in 6 referral centers (Yorkshire-Humber, UK) 
for patients with sustained deterioration of kidney function. Con-
senting (C) patients completed questionnaires after predialysis 
consultation (T1), and 6 weeks later (T2). Measures assessed 
YoDDA’s utility to support patients’ decisions and integration 
within usual care. 
♦ Results: Usual Care (n = 105) and +YoDDA (n = 84) participant 
characteristics were similar: male (62%), white (94%), age 
(mean = 62.6; standard deviation [SD] 14.4), kidney disease 
severity (glomerular filtration rate [eGFR] mean = 14.7; SD 3.7); 
decisional conflict was < 25; choice-preference for home versus 
hospital dialysis approximately 50:50. Patients valued receiving 
YoDDA, reading it on their own (96%), and sharing it with family 
(72%). The +YoDDA participants had higher scores for under-
standing kidney disease, reasoning about options, feeling in con-
trol, sharing their decision with family. Study engagement varied 
by center (estimated range 14 – 49%; mean 45%); participants 
varied in completion of decision quality measures.
♦ Conclusions: Receiving YoDDA as part of predialysis education 
was valued and useful to patients with worsening kidney disease. 
Integrating YoDDA actively within predialysis programs will meet 
clinical guidelines and patient need to support dialysis decision 
making in the context of patients’ lifestyle.
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Predialysis education programs are recommended best prac-tice for services (1–3). There is little guidance on how best 
to support patients making informed treatment decisions and, 
unsurprisingly, programs vary in their content and delivery 
across providers (4–6). All services provide leaflets to inform 
patients about their kidney disease and/or local services, but 
few are designed explicitly to support informed decision making 
(7). Studies indicate patients are satisfied with their involve-
ment in kidney care and disease management (5) but want more 
support in making dialysis decisions (6,8,9). Patients usually 
describe the dialysis decision as being between ‘dialysis’ and ‘no 
dialysis’, often commenting they had no choice about dialysis 
type (8,10–12). Few studies report any pre-choice reasoning by 
patients to consider which dialysis option fits best into their life.
Decision aids use decision science to structure the health-
care problem in a way that supports people’s ability to make 
reasoned decisions (13,14). Decision aids encourage people 
to consider accurate information about all options and their 
consequences without bias, evaluate this information in 
accordance with  their values, make a decision based on 
trade-offs between evaluations (15,16), and, in the healthcare 
context, discuss their reasoning with others to implement an 
agreed choice (17,18). Decision aids include different com-
ponents to facilitate decision making about the following 
(19–22): patients making reasoned decisions between options, 
i.e. patient decision aids (e.g. leaflets); professionals mak-
ing accurate treatment choices, i.e. clinical decision support 
(e.g. guidelines); patients and professionals collaborat-
ing more effectively in the process of choosing healthcare 
within consultations, i.e. shared decision making support 
(e.g. patient/professional prompts/training) (Supplementary 
Figure S1: Informed, evidence-based and shared decisions).
Delivering information that is evidence-based and enables 
understanding of the healthcare problem is fundamental to 
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ensuring patients’ preferences are informed and essential to 
patients’ deliberation with professionals about why a given 
option fits better into their lifestyle, at this time, than another. 
This paper describes the development of a patient decision 
aid, the Yorkshire Dialysis Decision Aid (YoDDA) booklet (23), 
and investigates a) its acceptability to people making dialysis 
decisions, and b) the feasibility of evaluating its effectiveness 
within usual care.
METHODS
SETTING AND DESIGN 
The study was carried out across all 6 predialysis services 
within Yorkshire-Humber (UK) from February 2012 to March 
2013. Between 5 and 30 patients with sustained deterioration 
of kidney function are referred, per center, to this region’s 
predialysis services each month. About 2,300 patients have 
dialysis; 80% have center hemodialysis (CHD; hospital or satel-
lite units), and 20% have home therapies (home hemodialysis, 
HHD; automated peritoneal dialysis, APD; continuous ambula-
tory peritoneal dialysis, CAPD) (24).
We selected a prospective non-randomized comparison 
study design with historic controls to minimize the impact of 
the research infrastructure on YoDDA’s assimilation into usual 
predialysis education practice (18,25,26). It is an appropriate 
design for investigating with rigor a) YoDDA’s efficacy and 
acceptability to predialysis patients and staff, and b) the fea-
sibility of evaluating this complex intervention’s effectiveness 
within usual care (27). The comparison groups were: 
•		 Usual	Care	–	all	patients	referred	to	predialysis	services	in	
February 2012 – August 2012; usual care involved educa-
tion (e.g. consultations, leaflets/videos, peer meetings, 
home visits) about conservative care and renal replacement 
therapy options for patients delivered by predialysis staff. 
•		 +YoDDA – all patients referred to predialysis services in 
September 2012 – March 2013; +YoDDA included usual 
predialysis care plus a copy of the YoDDA booklet, or the 
YoDDA booklet with additional self-report questions about 
their lifestyle and values (VT), delivered by predialysis staff.
  
INTERVENTION
The YoDDA booklet is designed for people with worsening 
kidney disease, and their family members, to make informed 
decisions between 2 dialysis options delivered in 2 ways, in 
the context of their lifestyle: hemodialysis, in a medical center 
(CHD) or at home (HHD); peritoneal dialysis, at home in an 
automated (APD) or continuous ambulatory (CAPD) form. Its 
purpose is to a) help people reason to the best of their ability 
about which dialysis option suits them, or their family member, 
at this time (13) and b) support discussions with health profes-
sionals about lifestyle, values, and medical history of relevance 
to their choice and its integration within their kidney disease 
management (17–19).
The YoDDA booklet was developed using a systematic meth-
od (18,28), including: review of clinical guidelines, service 
frameworks and existing patient information (Supplementary 
Box S2: Patient resources and experts) (1–3,7,29–32); patient 
and professional surveys of dialysis choices and kidney disease 
experience (5,9–12,33–38) using decision analysis (39) and 
behavioral decision support guidance (13–15,40–47) to cri-
tique the healthcare problem and patient information; testing 
its face-validity and utility prior to this acceptability research 
(Supplementary Table S3: Steps of YoDDA development). We 
applied decision support techniques to identify and structure 
the decision-relevant information in the context of disease 
management (48–50), de-bias the information presented, 
and encourage active reasoning about options in accordance 
with a person’s values (Supplementary Table S4: Function 
of techniques). 
The YoDDA booklet can be used independently by patients, 
their carers and their family, and/or with staff delivering pre-
dialysis care. It is 44 pages long (14 point font) with 5 sections: 
Introduction – service’s contact details, provenance, how to 
use YoDDA, and contents page; Section A – chronic and progres-
sive kidney disease, end stage renal failure, and conservative 
care and renal replacement treatments information; Section 
B – dialysis options, thinking about the decision, common 
features of dialysis, and differences; Section C – decision-
attribute summary table, and prompts to focus people on 
their lifestyle activities and treatment preferences; Section D 
– glossary, further information, research used. The Booklet’s 
average readability scores are an 8 – 9th grade education level 
(11 – 14 years old) (44).
SAMPLE 
All adult patients with chronic kidney disease referred 
to the Yorkshire-Humber predialysis services over the study 
period were eligible for inclusion in this study, an estimated 67 
patients per month. Statistical guidance (51) of 5 – 10 cases per 
outcome variable was used to estimate our sample size, i.e. a 
minimum of 80 – 100 patients per phase for measures assessing 
acceptability of information and patient-reported outcomes of 
informed decision making (52). Ethical approval was granted 
in October 2010 (ref: 10/H1302/72), and protocols registered 
(www.clinicaltrials.gov/show/NCT01671228). 
MATERIALS 
We developed: for patients – a study recruitment letter, 
information sheet, consent form, questionnaires (T1 after 
the predialysis education consultation, T2 6 weeks later); for 
staff – a clinical data sheet to record the number of patients 
referred to the service and participants’ details, a consultation 
checklist for predialysis nurses to note issues discussed with 
patients, and post-research impact questions for experiences 
of using YoDDA (contact authors for measures). 
The questionnaire included both validated and pre-tested 
questions (13,19,52–55) (Supplementary Table S3: Steps 
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of YoDDA development) to capture the varied outcomes of a 
complex intervention (27) evaluated within the delivery and 
experience of predialysis care, such as: staff disseminating, 
and patients reading, YoDDA; staff and patient experiences 
of using YoDDA and predialysis care; the efficacy of YoDDA to 
support patients’ informed decision making between dialysis 
options. The feasibility study explored the performance of 
several measures of decision making process and outcome. In 
predialysis care, decisions are made over time, are made with 
several professionals and/or consultations, are only imple-
mented when their disease worsens, may change as a result 
of a change in lifestyle or health state, impact on their daily 
management of chronic kidney disease, and can be reversed; 
decision quality measures have been validated in contexts 
with one-off, non-reversible decisions between treatment 
options in unfamiliar and acute health contexts, implemented 
immediately, or very soon after, a preference is stated (52). 
Patient measures assessed:
•		 Characteristics	(T1;	clinical	data	sheet):	age;	sex;	marital	
status; ethnicity; highest education level attained; annual 
income; disease state (estimated glomerular filtration rate 
[eGFR ]) and patient-reported health related quality of life 
(EQ-5D, 3-level version) (56).
•		 Usefulness	of	written	information:		how	easy	were	leaflets	to	
read, useful in helping understand kidney disease, dialysis 
and the decision, sufficient to make a decision (0 – 6; not 
at all – extremely) (T1, T2); satisfaction with predialysis 
care (0 – 10; not at all – extremely) (T2); use of YoDDA, i.e. 
read/show it to others (yes/no; T2). 
•		 Decision-making	processes:	views	of	control	over	choice,	
sharing decision with spouse/family/health professionals, 
knowing other patients’ choices (0 – 6; not at all – 
extremely) (T1, T2); views of others in decision making, and 
difficulty in refusing health professional’s recommendation 
(0 – 6; not at all – extremely) (T1, T2); dialysis choice prefer-
ence (rank order CHD; HHD; APD; CAPD) (T1, T2); dialysis 
and chronic kidney disease knowledge (9 multiple-choice 
items; T1, T2); perceived seriousness and risk complica-
tions HD and PD (0 – 6; T1; T2); Brief Illness Perception 
Questionnaire (8 items with 0 – 10 scale; T1) (57). 
•		 Validated	decision-making	process	and	outcome	measures:	
Stage of Decision Making (58) — one response from 6 
statements about reaching a preference (consent; T1, T2); 
Preparation for Decision Making (59) — we used 5 of the 10 
items assessing usefulness of written information to inform 
people about the decision and engage with health profes-
sionals (not at all, a little, somewhat, quite a bit, a great 
deal) (T1); Decisional Conflict Scale (60) – 16 items about 
making a reasoned decision (strongly disagree, disagree, 
neither agree nor disagree, agree, strongly agree) (T2). 
PROCEDURE 
The study team worked with the local hospital research 
nurses (part of the Comprehensive Local Research Network 
at Sheffield, Leeds, Doncaster, York, Bradford, and Hull NHS 
hospitals, funded by the UK National Institute of Health 
Research) and predialysis nurses to identify patients referred 
to the service prior to their consultation. Research nurses 
informed patients of the study either at clinic or by mail. 
Participants completed a consent form (C); non-participants 
continued with usual care; their details were forwarded to 
the University study team (HLB, AEW, TG, LM), who sent out 
a questionnaire immediately after participants’ predialysis 
education consultation (T1), and 6 weeks later (T2). Patients 
not returning questionnaires were contacted by telephone and 
sent another questionnaire (AEW, TG, LM). Research nurses 
recorded clinical data about participants from notes, and 
the number of patients using the service. Predialysis teams 
delivered usual care to all patients independently of patients’ 
study participation; in phase 2 staff handed out YoDDA to fit 
in with their predialysis education practices. (Supplementary 
Figure S5: Study Flow Diagram.)
ANALYSIS
Descriptive statistics summarize sample characteristics. 
MANOVA assess differences in information quality and decision 
making experience by Usual Care and +YoDDA groups, at T1 and 
T2; repeated measures analyses examine differences in experi-
ences over time. Data were analyzed using SPSS (version 20, 
SPSS, Chicago, IL, USA). We noted this sample was less likely to 
complete all questionnaire items than participants from other 
decision aid studies (53–55). Variables with missing responses 
> 10% were excluded from the analyses; mean substitution 
was used for variables with < 10% missing data (51). Those 
completing both questionnaires were older, more likely to be 
women, and less likely to want to have CHD compared with 
those who completed consent and T1. 
RESULTS
ACCEPTABILITY OF YODDA WITHIN PREDIALYSIS PROGRAMS
Overall, 189/274 (69%) consented patients completed 
questionnaire T1 (Usual Care, 72%; +YoDDA, 65%); 156/274 
(57%) completed questionnaire T1 and T2 (Usual Care, 59%; 
+YoDDA, 54%) (see Figure 1). Patient characteristics were 
similar across groups, when captured (Table 1). Participants’ 
mean eGFR was M = 14.5 (standard deviation [SD] = 4.22) 
and M = 14.8 (SD = 3.51) (Usual Care/+YoDDA respectively; 
F(1,87) = 0.15, p = 0.70), with noticeable deterioration in their 
health state (56) (Table 1). Patients’ dialysis preferences were 
around 50:50 for home:hospital options (Table 1). The study 
sample was representative of the region (24).  
The +YoDDA patients had higher scores than Usual Care 
patients for the usefulness of written information to support 
understanding about kidney disease and dialysis options 
(Table 2), clarity of thinking about the decision in accordance 
with their values (59) (Table 3), and feeling in control of the 
choice, and sharing decision making with their family (Table 4). 
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(Usual Care M = 8.13, SD = 2.34; +YoDDA M = 8.66, SD = 1.67; 
F(1,187) = 3.04, p = 0.08) and participants felt able to engage 
with kidney health professionals (59) (Table 3). 
Most (96%) patients reported reading YoDDA, 66% more 
than once; 72% showed it to someone else; 23% wrote notes 
in it. Patients’ comments (from questionnaire and pilot inter-
views) were positive, focusing on:
•		 Content:	“All	the	information	enclosed	was	useful	explicit	
and informative. I feel the booklet cannot be improved 
upon. Perfect” (patient 52) 
•		 Length/Literacy:	 ‘I	 like	 the	 fact	 that	 it’s	got	a	 lot	more	
information, you can come and just do sections of it. It’s 
very easy to read … it wouldn’t be a chore to go through it’ 
(patient 20 – pilot )
•		 Balance/Neutral:	‘I	think	it’s	good…	written	in	a	way	that	
it makes it easier to take in and understand. It is aimed at 
patients not at people that are treating patients... it gives 
For all participants, the views of family and professionals, but 
not other patients, were important to their decision making 
(Table 4); satisfaction with the predialysis team was high 
Figure 1 — Stage of Decision Making (58) Mean Responses at Consent, 
T1 & T2 by group. YoDDA = Yorkshire Dialysis Decision Aid.
TABLE 1 
Socio-Demographic and Clinical Characteristics by Study Group at T1
 Usual Care (n=105) +YoDDA (n=84)
  n (%) n (%) p 
Sex Male 67 (66) 53 (65) 0.16
Marital status Married/cohabiting 70 (69) 56 (69) 0.77
Co-habiting family Children 21 (20) 16 (20) 0.07
 Other 6 (6) 5 (7) 0.31
Ethnic origin White 93 (94) 77 (96) 0.66
Education No school qualification 32 (38) 23 (30) 0.72
  (<16 years old)
 Secondary school + 32 (37) 30 (39)
  (16+ years old)
 Professional qualification 21 (25) 24 (31) 
Employment status Working 27  (28) 23 (29) 0.15
 Retired 56 (57) 35 (44)
 Other 15 (15) 22 (27) 
Annual income <£20,000 51 (61) 36 (59) 0.76
 £21,000–£40,000 19 (23) 17 (28)
 £41,000 + 13 (16) 8 (13) 
Preferred dialysis  HD–center 46 (50) 41 (54)
 option at T2 HD–home 10 (11) 9 (12) 0.79
 PD–CAPD 10 (11) 5 (7)
 PD–APD 25 (28) 20 (27) 
  n M (SD) n M (SD) p
Age  100 62.27 (12.30) 81 63.09 (16.70) 0.71
EQ-5D (56) utility I Death–Best Possible 96 0.69 (0.31) 77 0.71 (0.25) 0.61
 (from 5 items)   Health (0–1)  
EQ-5D (56) utility II Worst Imaginable–Best 78 58.00 (21.06) 52 62.27 (18.44) 0.24
 (analogue scale)  Imaginable Health State
  (0–100)
+YoDDA = Usual Care Plus Yorkshire Dialysis Decision Aid; HD = hemodialysis; PD = peritoneal dialysis; CAPD = continuous ambulatory peritoneal 
dialysis; APD = automated peritoneal dialysis; M = mean; SD = standard deviation.
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an overview to everything evenly so you can make a proper 
informed choice rather than thinking that [it is] sponsored 
by X’ (patient 21 – pilot )
•		 Medium:	‘So	I	don’t	think	you	would	be	able	to	do	a	com-
puter thing would you really? You best … just stick with this 
[booklet]…’ (patient 3 – pilot interview)
•		 Utility:	‘Yeah,	I	think	you	know,	in	paper	form	people	can	
just flip over it they think they know it and they just skim 
read it and go ‘know that’ (patient 16 – pilot)
•		 Integration	into	services:	“The	information	was	good	to	use	
alongside the help from the predialysis team” (patient 94)
•		 Supporting	informed	decision	making:	“The	description	of	
TABLE 2 
Patient Views of Predialysis Written Information by Study Group
 Usual Care +YoDDA
Items scored: n=105 n=84
Not at all 0-1-2-3-4-5-6 Very much M (SD) M (SD) p value
The information was easy to understand 4.39 (1.49) 4.58 (1.69) 0.46
The information was enough to make a decision 3.62 (1.73) 4.06 (1.39) 0.06
The information helped me understand CKD 4.35 (1.49) 4.88 (1.42) 0.01
The information helped me understand dialysis 4.51 (1.41) 4.88 (1.26) 0.06
YoDDA = Yorkshire Dialysis Decision Aid; M = mean; SD = standard deviation; CKD = chronic kidney disease.
TABLE 3 
Preparation for Decision Making (59) by Study Group
  Usual Care +YoDDA
Items scored: n=105 n=84
Not at all 0-1-2-3-4 Very much M (SD) M (SD) p value
Informed Decision Making Items
 Help you recognize that a decision needs to be made? 2.91 (0.96) 3.12 (0.92) 0.07
 Help you think about the advantages and disadvantages of each option?  2.77 (1.05) 3.09 (0.93) 0.03
 Help you organize your own thoughts about the decision?  2.72 (1.03) 3.03 (1.02) 0.05
Engagement Healthcare Process Items
 Help you think about how involved you want to be in this decision? 3.06 (1.00) 3.28 (0.96) 0.12
 Help you identify questions you want to ask your doctor?  2.79 (1.04) 2.71 (1.20) 0.63
YoDDA = Yorkshire Dialysis Decision Aid; M = mean; SD = standard deviation.
TABLE 4 
Perceived Autonomy and Others’ Role in Decision Making by Study Group
  Usual Care +YoDDA
Items scored: n=105 n=84
Not at all 0-1-2-3-4-5-6 Very much M (SD) M (SD) p value
I feel I have no control over this dialysis choice.  1.96 (2.14) 1.37 (1.94) 0.05
How important is it to your decision to know what dialysis treatment  
 other patients choose?  
2.47 (1.94) 2.26 (1.84) 0.45
How important is it to you that you share this decision with your  
 spouse/carer/family? 
5.08 (1.68) 5.51 (1.20) 0.05
The views of my family and people close to me are important in my choice. 4.85 (1.73) 4.92 (1.42) 0.78
It would be difficult for me to say no if my spouse/carer wanted me to  
 have one treatment over another.  
3.13 (1.90) 2.99 (1.94) 0.63
How important is it to you that you share this decision with the doctor  
 and/or nurses? 
5.02 (1.52) 4.92 (1.40) 0.62
It would be difficult for me to say no if my doctor recommended one  
 treatment over another. 
3.52 (1.96) 3.88 (1.78) 0.20
 YoDDA = Yorkshire Dialysis Decision Aid; M = mean; SD = standard deviation.
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the different treatments…allowed me to make my treatment 
decision” (patient 62)
•		 Improvements:	“The	booklet	needs	to	indicate	more	where	
all support for the patient can be found from including 
benefit support and carers support and how to access this 
support” (patient 126)
Patients completing consent (C), T1, and T2 questionnaires 
engaged with making a choice over time (58) (Usual Care, Wilk’s 
Lambda = 0.76, F(2,99) = 15.73, p = 0×00); +YoDDA, Wilk’s 
Lambda = 0.66, F(2,78) = 20.40, p = 0.00). A larger number 
of +YoDDA patients formed a treatment preference over this 
time than Usual Care patients (Usual Care M = 4.38; +YoDDA 
M = 4.82, F(1,187) = 3.12, p = 0.08) (Figure 1) (52).
FEASIBILITY OF EVALUATING YODDA WITHIN USUAL PRACTICE
Delays by hospital research and development offices, 
annual leave, and staff changes meant centers did not start 
capturing data at the same time. Few centers captured all 
patients referred to predialysis services, only those consent-
ing to the study. Using average, pre-study estimated referral 
rates to the 6 centers for 7 months (n = 469), a conservative 
estimated study uptake was Usual Care = 31% and +YoDDA = 
28% with by-center variation (Usual Care, 0 – 81%; +YoDDA, 
11 – 97%). When captured by centers, +YoDDA study uptake 
was 45% (58/129), with by-center variation (14 – 49%).
Predialysis staff disseminated YoDDA in ways to suit their 
delivery of care: adding YoDDA to their usual leaflet pack; add-
ing YoDDA to their leaflet pack and encouraging patients to 
read it; giving YoDDA as the only leaflet. The predialysis teams 
distributed 2 versions of YoDDA when pre-stacked in alternate 
order. Only one participant (2%) reported not receiving YoDDA. 
Four centers continued handing out YoDDA post study. 
Staf f did not complete the consultation checklists. 
Participants did not complete several items in self-report ques-
tionnaires, including: knowledge; risk perceptions; balance of 
information; values toward treatment attributes; Brief Illness 
Perception Questionnaire (39). Patients’ decisional conflict 
scores (60) were lower than 25, suggesting participants were 
not experiencing decisional conflict and/or the measure 
was unable to capture decisional uncertainty in this context 
(Usual Care M = 13.83, SD = 9.37; +YoDDA M = 13.60 SD = 9.75; 
F(1,187) = 0.03, p = 0.87). 
DISCUSSION
Study participants valued receiving YoDDA when mak-
ing treatment decisions about established kidney disease, 
finding it acceptable to read on their own and share it with 
family members. The pattern of results suggest YoDDA is 
valid (13–15,16,18,19) providing a more efficacious way of 
helping patients’ assimilate, and reason about, accurate 
information about all treatment options for their worsen-
ing kidney disease in order to make trade-offs between 
the consequences for their health and lifestyle. In keep-
ing with previous research (5,8,10), patients report being 
satisfied with their predialysis service and engagement with 
kidney professionals. 
Patients from all 6 centers received YoDDA, with some 
staff using it proactively to support predialysis education. 
In a similar way to clinical guidelines for those delivering 
evidence-based services (1–3), YoDDA provides generic, 
accurate, balanced, accessible information to support people’s 
thinking about all options and consequences of managing 
established kidney disease in the context of their lifestyle, as 
well as ways of engaging with predialysis services including 
prompts to discuss lifestyle, disease management experiences, 
and treatment preferences. It is likely patients and staff using 
YoDDA actively within predialysis consultations will enable 
personalized information about a patient’s medical history and 
local services to be assimilated alongside informed reasoning 
between treatment preferences, leading to more effective col-
laborative care planning (20,22). Fortnum and colleagues (32) 
found shared decision making training an essential component 
to address variations in staff practices and enable the integra-
tion of decision aids across predialysis services.
We employed a pragmatic design to evaluate YoDDA with 
patients and staff within predialysis programs, and minimize 
the research methods’ impact on usual care. The socio- 
demographic and clinical characteristics suggest participants 
were similar to the region’s predialysis patients (24), indicat-
ing the YoDDA booklet was acceptable to patients across age, 
sex, educational, financial, and health state groups. The 
uptake rate patterns suggest staff decisions about patient 
eligibility and/or research engagement varied by center, 
perhaps resulting from differences in service infrastructure 
and/or staff views toward either research about shared deci-
sion making or the utility of a decision aid booklet to patients 
with worsening health states. These methods relied on self-
completion questionnaires, meaning views of non-participants 
are not captured. It is unclear whether non-participants held 
similar views to those of participants, or were experiencing 
more or less uncertainty about their choice, satisfaction with 
 predialysis teams, and usefulness of patient leaflets.
CONCLUSIONS
YoDDA helps patients think differently about the problem 
of choosing between treatments to manage their worsening 
kidney disease and evaluate them in accordance with their life-
style. The booklet can be integrated across different predialysis 
services, and complements usual practice. Providing YoDDA 
enables services to meet current clinical guidance on inform-
ing patients of all treatments for established kidney disease 
and patient need for more support in dialysis decision making. 
Integrating YoDDA proactively within predialysis consultations 
is likely to enhance collaborative care planning about dialysis 
regimens between patients and predialysis services. Evaluating 
YoDDA’s effectiveness has 2 challenges. First, staff and patient 
variation in decision aid use is likely to impact differentially 
on decision making and service quality indicators. Second, 
current patient-reported measures of informed decision 
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making may not capture reliably patients’ outcomes in this 
clinical context.
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